Thalia Therapeutics Plc (AIM:THAT)
London · Delayed Price · Currency is GBP · Price in GBX 0.6750
0.00 (0.00%)
Aug 14, 2026, 2:29 PM GMT
Thalia Therapeutics Revenue
Thalia Therapeutics had revenue of 3.69K GBP in the half year ending June 30, 2025. This brings the company's revenue in the last twelve months to 7.28M, up 272.11% year-over-year. In the year 2024, Thalia Therapeutics had annual revenue of 7.28M with 372,762.26% growth.
Revenue (ttm)
7.28M
Revenue Growth
+272.11%
P/S Ratio
773.39
Revenue / Employee
2.42K
Employees
3
Market Cap
5.62M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.28M | 7.28M | 372,762.26% |
| Dec 31, 2023 | 1.95K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | 1.16M | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | 2.26M | -417.00K | -15.57% |
| Dec 31, 2012 | 2.68M | -292.00K | -9.83% |
| Dec 31, 2011 | 2.97M | 1.05M | 54.77% |
| Dec 31, 2010 | 1.92M | 52.00K | 2.79% |
| Dec 31, 2009 | 1.87M | -110.00K | -5.56% |
| Dec 31, 2008 | 1.98M | 413.00K | 26.41% |
| Dec 31, 2007 | 1.56M | 166.00K | 11.87% |
| Dec 31, 2006 | 1.40M | 324.00K | 30.17% |
| Dec 31, 2005 | 1.07M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Palatin Technologies | 9.76M |
| Futura Medical | 1.70M |
| Fusion Antibodies | 1.60M |
| Oxford BioDynamics | 1.20M |
| OptiBiotix Health | 1.17M |
| Genflow Biosciences | 585.61K |
| CRISM Therapeutics | 231.00K |
| Solvonis Therapeutics | 31.87K |